Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage
about
Investigational antimicrobial agents of 2013.Natural product and natural product derived drugs in clinical trials.Reducing antibacterial development risk for GSK1322322 by exploring potential human dose regimens in nonclinical efficacy studies using immunocompetent rats.Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution.In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates
P2860
Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Penetration of GSK1322322 into ...... ined by bronchoalveolar lavage
@en
Penetration of GSK1322322 into ...... ned by bronchoalveolar lavage.
@nl
type
label
Penetration of GSK1322322 into ...... ined by bronchoalveolar lavage
@en
Penetration of GSK1322322 into ...... ned by bronchoalveolar lavage.
@nl
prefLabel
Penetration of GSK1322322 into ...... ined by bronchoalveolar lavage
@en
Penetration of GSK1322322 into ...... ned by bronchoalveolar lavage.
@nl
P2093
P2860
P356
P1476
Penetration of GSK1322322 into ...... ined by bronchoalveolar lavage
@en
P2093
Chester L Bowen
Etienne Dumont
John Z Zhu
Keith A Rodvold
Liangfu Chen
Lori S Jones
Odin J Naderer
P2860
P304
P356
10.1128/AAC.01836-13
P407
P577
2013-11-04T00:00:00Z